Indian Company Master Data Made Simple
Beryl Drugs Limited
Founded in 1993, Beryl Drugs Limited has been operating for more than 32 years. Corporate ID: L02423MP1993PLC007840, registered with number 7840. The firm is categorized as company limited by shares. Its authorized share capital is ₹10.00 crore. Its paid up capital is ₹5.07 crore.
The firm focuses on forestry, logging and related service activities. Registered under the jurisdiction of Gwalior. Beryl Drugs Limited’s registered office is at 133 Kanchan Bagh, Indore, Indore, Madhya Pradesh, India, 452001. The company is currently active. The Legal Entity Identifier assigned to the company is 984500CC594C0ZE90971. Beryl Drugs Limited can be contacted at [email protected]. The leadership team includes Ashish Baraskar (CFO).
Profile data last updated: 14/12/2024
Company Overview
- CIN
- Date of Incorporation
- 24/08/1993
- Company Status
- Active
- RoC
- Gwalior
- Registration Number
- Balance sheet date
- 31/03/2024
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- Authorized Capital
- ₹10,00,00,000.00
- Paid up Capital
- ₹5,07,17,000.00
- Activity
- FORESTRY, LOGGING AND RELATED SERVICE ACTIVITIES
- [email protected]
- PAN
Balance Sheet
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|
| Total Non Current Liabilities Net Minority Interest | ₹215.61L | ₹280.81L | ₹310.29L | ₹203.77L |
| Investment Properties | ₹19.59L | ₹20.39L | ₹21.39L | ₹18.00L |
| Accumulated Depreciation | -₹690.59L | -₹566.84L | -₹461.49L | -₹381.38L |
| Total Liabilities Net Minority Interest | ₹645.62L | ₹856.36L | ₹944.51L | ₹1,053.02L |
| Tangible Book Value | ₹950.30L | ₹892.21L | ₹806.55L | ₹729.15L |
| Long Term Debt | ₹173.58L | ₹240.38L | ₹270.61L | ₹167.52L |
| Long Term Provisions | ₹42.04L | ₹40.44L | ₹39.69L | ₹36.26L |
| Current Debt And Capital Lease Obligation | ₹233.77L | ₹269.02L | ₹183.61L | ₹361.84L |
| Machinery Furniture Equipment | ₹880.62L | ₹827.41L | ₹742.52L | ₹660.85L |
| Total Assets | ₹1,596.00L | ₹1,748.69L | ₹1,751.14L | ₹1,782.38L |
| Total Equity Gross Minority Interest | ₹950.38L | ₹892.33L | ₹806.63L | ₹729.36L |
| Gross PPE | ₹1,291.04L | ₹1,162.96L | ₹1,042.51L | ₹967.33L |
| Common Stock | ₹509.37L | ₹509.37L | ₹509.37L | ₹509.37L |
| Total Capitalization | ₹1,123.97L | ₹1,132.71L | ₹1,077.25L | ₹896.88L |
| Goodwill And Other Intangible Assets | ₹0.09L | ₹0.12L | ₹0.09L | ₹0.21L |
| Total Debt | ₹407.35L | ₹509.40L | ₹454.22L | ₹529.36L |
| Other Equity Interest | ₹441.01L | ₹382.96L | ₹297.27L | ₹219.99L |
| Other Non Current Liabilities | -₹0.01L | -₹0.01L | -₹0.01L | -₹0.01L |
| Capital Stock | ₹509.37L | ₹509.37L | ₹509.37L | ₹509.37L |
| Total Non Current Assets | ₹691.55L | ₹736.32L | ₹712.26L | ₹729.17L |
| Cash Cash Equivalents And Short Term Investments | ₹88.09L | ₹12.50L | ₹57.38L | ₹67.16L |
| Invested Capital | ₹1,357.74L | ₹1,401.73L | ₹1,260.86L | ₹1,258.72L |
| Net Tangible Assets | ₹950.30L | ₹892.21L | ₹806.55L | ₹729.15L |
| Cash And Cash Equivalents | ₹81.43L | ₹12.50L | ₹28.30L | ₹27.14L |
| Prepaid Assets | ₹44.15L | ₹101.91L | ₹121.29L | ₹68.35L |
| Stockholders Equity | ₹950.39L | ₹892.33L | ₹806.64L | ₹729.36L |
| Other Short Term Investments | ₹6.66L | ₹9.82L | ₹29.08L | ₹40.02L |
| Share Issued | ₹50.72L | ₹50.72L | ₹50.72L | ₹50.72L |
| Current Assets | ₹904.45L | ₹1,012.37L | ₹1,038.88L | ₹1,053.21L |
| Working Capital | ₹474.44L | ₹436.82L | ₹404.66L | ₹203.96L |
| Net Debt | ₹325.92L | ₹496.90L | ₹425.92L | ₹502.22L |
| Ordinary Shares Number | ₹50.72L | ₹50.72L | ₹50.72L | ₹50.72L |
| Current Debt | ₹233.77L | ₹269.02L | ₹183.61L | ₹361.84L |
| Long Term Debt And Capital Lease Obligation | ₹173.58L | ₹240.38L | ₹270.61L | ₹167.52L |
| Current Liabilities | ₹430.01L | ₹575.55L | ₹634.22L | ₹849.25L |
| Retained Earnings | ₹434.67L | ₹376.78L | ₹299.92L | ₹223.31L |
| Net PPE | ₹600.45L | ₹596.12L | ₹581.02L | ₹585.95L |
| Construction In Progress | ₹5.59L | ₹5.59L | ₹5.59L | ₹5.59L |
| Other Non Current Assets | ₹46.92L | -₹0.03L | ₹0.05L | ₹0.01L |
| Common Stock Equity | ₹950.39L | ₹892.33L | ₹806.64L | ₹729.36L |
| Other Intangible Assets | ₹0.09L | ₹0.12L | ₹0.09L | ₹0.21L |
| Inventory | ₹190.28L | ₹126.02L | ₹105.47L | ₹297.82L |
| Other Properties | ₹140.16L | ₹65.31L | ₹64.26L | ₹64.26L |
Cash Flow
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|
| Changes In Cash | ₹68.94L | -₹15.83L | ₹1.16L | -₹18.07L |
| Financing Cash Flow | -₹155.01L | ₹10.32L | -₹120.22L | -₹23.59L |
| Investing Cash Flow | -₹39.71L | -₹108.17L | -₹117.73L | ₹52.40L |
| Free Cash Flow | ₹45.15L | -₹53.14L | ₹82.76L | -₹88.43L |
| End Cash Position | ₹81.44L | ₹12.49L | ₹28.31L | ₹27.14L |
| Other Cash Adjustment Outside Changein Cash | ₹0.01L | ₹0.01L | ₹0.01L | ₹0.00L |
| Capital Expenditure | -₹218.51L | -₹135.16L | -₹156.35L | -₹41.55L |
| Beginning Cash Position | ₹12.49L | ₹28.31L | ₹27.14L | ₹45.21L |
| Operating Cash Flow | ₹263.66L | ₹82.02L | ₹239.11L | -₹46.88L |
Income Statement
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|
| Rent Expense Supplemental | ₹1.48L | ₹2.24L | ₹1.65L | ₹1.82L |
| Net Income From Continuing Operation Net Minority Interest | ₹57.88L | ₹76.86L | ₹76.60L | -₹65.90L |
| Net Income Discontinuous Operations | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Basic EPS | ₹0.00L | ₹0.00L | ₹0.00L | -₹0.00L |
| EBITDA | ₹262.99L | ₹265.82L | ₹221.60L | ₹55.62L |
| Total Expenses | ₹2,068.98L | ₹2,526.86L | ₹2,549.78L | ₹1,510.99L |
| Total Unusual Items | ₹87.97L | -₹7.55L | -₹0.94L | ₹0.00L |
| Operating Revenue | ₹2,094.41L | ₹2,644.67L | ₹2,668.90L | ₹1,445.45L |
| Tax Effect Of Unusual Items | ₹29.14L | -₹1.80L | -₹0.21L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | ₹87.97L | -₹7.55L | -₹0.94L | ₹0.00L |
| Interest Income Non Operating | ₹1.90L | ₹2.12L | ₹1.15L | ₹1.39L |
| Interest Income | ₹1.90L | ₹2.12L | ₹1.15L | ₹1.39L |
| Interest Expense Non Operating | ₹51.86L | ₹44.78L | ₹41.77L | ₹42.00L |
| Net Income From Continuing And Discontinued Operation | ₹57.88L | ₹76.86L | ₹76.60L | -₹65.90L |
| General And Administrative Expense | ₹39.71L | ₹37.09L | ₹37.04L | ₹34.70L |
| Reconciled Depreciation | ₹124.56L | ₹120.07L | ₹81.44L | ₹108.65L |
| Net Income Continuous Operations | ₹57.88L | ₹76.86L | ₹76.60L | -₹65.90L |
| Reconciled Cost Of Revenue | ₹1,464.74L | ₹1,776.91L | ₹1,856.80L | ₹1,042.63L |
| Operating Income | ₹25.43L | ₹117.81L | ₹119.12L | -₹65.54L |
| Net Income | ₹57.88L | ₹76.86L | ₹76.60L | -₹65.90L |
| Diluted Average Shares | ₹50.72L | ₹50.72L | ₹50.72L | ₹50.72L |
| Selling And Marketing Expense | ₹222.69L | ₹387.86L | ₹403.97L | ₹179.26L |
| Total Other Finance Cost | ₹1.65L | ₹2.58L | ₹4.88L | ₹4.02L |
| Normalized Income | -₹0.95L | ₹82.61L | ₹77.33L | -₹65.90L |
| Net Non Operating Interest Income Expense | -₹51.61L | -₹45.24L | -₹45.50L | -₹44.63L |
| Gross Profit | ₹629.67L | ₹867.76L | ₹812.10L | ₹402.82L |
| EBIT | ₹138.43L | ₹145.75L | ₹140.16L | -₹53.03L |
| Cost Of Revenue | ₹1,464.74L | ₹1,776.91L | ₹1,856.80L | ₹1,042.63L |
| Diluted NIAvailto Com Stockholders | ₹57.88L | ₹76.86L | ₹76.60L | -₹65.90L |
| Net Interest Income | -₹51.61L | -₹45.24L | -₹45.50L | -₹44.63L |
| Operating Expense | ₹604.24L | ₹749.95L | ₹692.98L | ₹468.36L |
| Normalized EBITDA | ₹175.02L | ₹273.37L | ₹222.54L | ₹55.62L |
| Net Income Common Stockholders | ₹57.88L | ₹76.86L | ₹76.60L | -₹65.90L |
| Pretax Income | ₹86.57L | ₹100.97L | ₹98.39L | -₹95.03L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Selling General And Administration | ₹262.40L | ₹424.95L | ₹441.01L | ₹213.96L |
| Total Revenue | ₹2,094.41L | ₹2,644.67L | ₹2,668.90L | ₹1,445.45L |
| Other Operating Expenses | ₹14.09L | ₹37.55L | ₹16.60L | ₹26.78L |
| Diluted EPS | ₹0.00L | ₹0.00L | ₹0.00L | -₹0.00L |
| Interest Expense | ₹51.86L | ₹44.78L | ₹41.77L | ₹42.00L |
| Basic Average Shares | ₹50.72L | ₹50.72L | ₹50.72L | ₹50.72L |
| Net Income Including Noncontrolling Interests | ₹57.88L | ₹76.86L | ₹76.60L | -₹65.90L |
| Tax Provision | ₹28.68L | ₹24.11L | ₹21.78L | -₹29.13L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 12/12/2000 | Sudhir Sethi | 00090172 | Director | View other directorships |
| 12/12/2000 | Sanjay Sethi | 00090277 | Managing Director | View other directorships |
| 01/05/2014 | Neha Sharma | *****8725F | Company Secretary | |
| 04/09/2014 | Ashish Baraskar | *****2172P | CFO | |
| 30/05/2019 | Shreya Saraf | 08456151 | Director | View other directorships |
| 30/05/2019 | Abhinav Naik | 08456140 | Director | View other directorships |
Latest Documents
Category:
| Date | Title | Size |
|---|---|---|
| 03/12/2024 | Form MGT-7-03122024_signed | - |
| 10/10/2024 | Form AOC-4(XBRL)-09102024 | - |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Bonanza Biotech Limited | L02423MP1981PLC001779 | 203, Apolo Tower, 2, M.g. Road, Indore, Madhya Pradesh, India, 000000 |
| Kabra Drugs Limited | L02423MP1989PLC005438 | 208 Swadesh Bhavan, 2 Press Complex, Ab Road, Indore R.s.s.nagar, Indore, Indore, Madhya Pradesh, India, 452011 |
Address
133 Kanchan Bagh, Indore, Indore, Madhya Pradesh, India, 452001
FAQ
What is the incorporation date of Beryl Drugs Limited?
The incorporation date of Beryl Drugs Limited is 24/08/1993.
Who are the current board members & directors of Beryl Drugs Limited?
The current board member of Beryl Drugs Limited are:
- Shreya Saraf
- Sudhir Sethi
- Shreya Saraf
- Sudhir Sethi
- Abhinav Naik
- Sanjay Sethi
What is the registered address of Beryl Drugs Limited?
The registered address of Beryl Drugs Limited is 133 Kanchan Bagh, Indore, Indore, Madhya Pradesh, India, 452001.
What is the Corporate Identification Number of Beryl Drugs Limited?
The Corporate Identification Number of Beryl Drugs Limited is L02423MP1993PLC007840.